Jin Medical International Stock Cash Per Share

ZJYL Stock   0.98  0.10  11.36%   
JIN MEDICAL INTERNATIONAL fundamentals help investors to digest information that contributes to JIN MEDICAL's financial success or failures. It also enables traders to predict the movement of JIN Stock. The fundamental analysis module provides a way to measure JIN MEDICAL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to JIN MEDICAL stock.
Last ReportedProjected for Next Year
Cash Per Share 2.07  2.17 
Cash Per Share is expected to rise to 2.17 this year.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

JIN MEDICAL INTERNATIONAL Company Cash Per Share Analysis

JIN MEDICAL's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Current JIN MEDICAL Cash Per Share

    
  2.17  
Most of JIN MEDICAL's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, JIN MEDICAL INTERNATIONAL is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

JIN Cash Per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for JIN MEDICAL is extremely important. It helps to project a fair market value of JIN Stock properly, considering its historical fundamentals such as Cash Per Share. Since JIN MEDICAL's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of JIN MEDICAL's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of JIN MEDICAL's interrelated accounts and indicators.
0.980.84-0.44-0.540.89-0.87-0.360.92-0.361.00.78-0.84-0.6-0.830.990.790.980.97
0.980.93-0.41-0.70.96-0.88-0.510.9-0.520.980.88-0.84-0.69-0.920.980.890.941.0
0.840.93-0.25-0.90.98-0.77-0.660.78-0.760.850.98-0.76-0.82-0.960.840.990.80.93
-0.44-0.41-0.250.01-0.350.680.07-0.470.13-0.44-0.10.630.070.43-0.48-0.11-0.49-0.41
-0.54-0.7-0.90.01-0.840.550.87-0.590.91-0.56-0.90.580.840.87-0.54-0.93-0.48-0.7
0.890.960.98-0.35-0.84-0.81-0.670.85-0.690.90.93-0.82-0.85-0.980.890.950.850.96
-0.87-0.88-0.770.680.55-0.810.44-0.90.52-0.87-0.690.940.430.85-0.88-0.7-0.87-0.88
-0.36-0.51-0.660.070.87-0.670.44-0.50.78-0.38-0.640.480.760.74-0.37-0.7-0.24-0.52
0.920.90.78-0.47-0.590.85-0.9-0.5-0.50.910.7-0.95-0.61-0.850.880.740.910.89
-0.36-0.52-0.760.130.91-0.690.520.78-0.5-0.38-0.740.610.70.8-0.35-0.78-0.36-0.51
1.00.980.85-0.44-0.560.9-0.87-0.380.91-0.380.8-0.84-0.61-0.841.00.80.970.98
0.780.880.98-0.1-0.90.93-0.69-0.640.7-0.740.8-0.66-0.76-0.910.790.990.730.89
-0.84-0.84-0.760.630.58-0.820.940.48-0.950.61-0.84-0.660.560.87-0.82-0.7-0.87-0.83
-0.6-0.69-0.820.070.84-0.850.430.76-0.610.7-0.61-0.760.560.82-0.58-0.83-0.54-0.69
-0.83-0.92-0.960.430.87-0.980.850.74-0.850.8-0.84-0.910.870.82-0.83-0.93-0.8-0.92
0.990.980.84-0.48-0.540.89-0.88-0.370.88-0.351.00.79-0.82-0.58-0.830.780.960.98
0.790.890.99-0.11-0.930.95-0.7-0.70.74-0.780.80.99-0.7-0.83-0.930.780.740.89
0.980.940.8-0.49-0.480.85-0.87-0.240.91-0.360.970.73-0.87-0.54-0.80.960.740.93
0.971.00.93-0.41-0.70.96-0.88-0.520.89-0.510.980.89-0.83-0.69-0.920.980.890.93
Click cells to compare fundamentals

JIN Cash Per Share Historical Pattern

Today, most investors in JIN MEDICAL Stock are looking for potential investment opportunities by analyzing not only static indicators but also various JIN MEDICAL's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's cash per share growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of JIN MEDICAL cash per share as a starting point in their analysis.
   JIN MEDICAL Cash Per Share   
       Timeline  
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Competition

JIN Common Stock Shares Outstanding

Common Stock Shares Outstanding

6.89 Million

At this time, JIN MEDICAL's Common Stock Shares Outstanding is quite stable compared to the past year.

JIN Cash Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses JIN MEDICAL's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of JIN MEDICAL could also be used in its relative valuation, which is a method of valuing JIN MEDICAL by comparing valuation metrics of similar companies.
JIN MEDICAL is currently under evaluation in cash per share category among its peers.

JIN Fundamentals

About JIN MEDICAL Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze JIN MEDICAL INTERNATIONAL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of JIN MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of JIN MEDICAL INTERNATIONAL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether JIN MEDICAL INTERNATIONAL is a strong investment it is important to analyze JIN MEDICAL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact JIN MEDICAL's future performance. For an informed investment choice regarding JIN Stock, refer to the following important reports:
Check out JIN MEDICAL Piotroski F Score and JIN MEDICAL Altman Z Score analysis.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.12)
Earnings Share
0.02
Revenue Per Share
0.129
Quarterly Revenue Growth
0.03
Return On Assets
0.0403
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.